Subject: Collaboration on Upcoming QC Protocols

---

From: Tracy Mcfarland <caleboneal@example.com>  
To: Daryl Daugherty <afoley@example.com>  
Date: October 10, 2023, 9:15 AM  

Hi Daryl,

I hope this message finds you well. I'm reaching out regarding the upcoming Quality Control protocols for the new batch of the R&D project we're initiating next month. Given your expertise in chemical engineering, I believe your insights would be invaluable in refining our approach to ensure compliance with the latest regulatory standards.

Could we schedule a meeting to discuss this in more detail? I'm aiming to have a draft ready by October 20th, so any time before then would be ideal. Let me know your availability this week or early next.

Additionally, please be informed that I'll be out of the office from November 3rd to 7th for an industry conference, so I would like to wrap up our initial discussions before my departure.

Looking forward to your thoughts.

Best regards,  
Tracy Mcfarland  
Research Officer, Government  
Merck & Co.  
caleboneal@example.com  
(555) 123-4567

---

From: Daryl Daugherty <afoley@example.com>  
To: Tracy Mcfarland <caleboneal@example.com>  
Date: October 10, 2023, 1:42 PM  

Hi Tracy,

Thanks for reaching out. I'd be glad to contribute to the QC protocol development. Ensuring regulatory compliance is crucial, and I have some ideas on optimizing the chemical processes to meet the new guidelines effectively.

I am available this Thursday at 2 PM or Friday morning if that suits your schedule. We can meet in the third-floor conference room, or I can join via Teams if you prefer a virtual meeting.

Also, I've been reviewing the latest FDA updates, and I believe there are some key changes we need to address. Let's ensure these are integrated into our protocols during our discussion.

Looking forward to collaborating on this project.

Best,  
Daryl Daugherty  
Engineer, Chemical  
Merck & Co.  
afoley@example.com  
(555) 987-6543